Pharvaris (PHVS) Gross Profit Growth (1y) (2026)
Powered by 
Analysis
Pharvaris (PHVS) Gross Profit Growth (1y) (2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 63.56 Bn | 58.37 Bn | 1.37 Bn | 63.51% |
| 4 | Moderna | 58.22 Bn | 53.09 Bn | 52.00 Mn | 126.09% |
| 5 | Revolution Medicines | 44.18 Bn | 44.18 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 33.01% |
| 7 | Alnylam Pharmaceuticals | 35.31 Bn | 32.00 Bn | 992.69 Mn | 57.16% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 351.57% |
| 10 | Pharvaris | 2.15 Bn | 1.78 Bn | 85,072.10 | -89.73% |